π₯π BizChicken ππ₯
Companies Similar to Vir Biotechnology, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Anixa Biosciences, Inc.
Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines
Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.
Symbol: ANIX
Recent Price: $2.50
Industry: Biotechnology
CEO: Dr. Amit Kumar Ph.D.
Sector: Healthcare
Employees: 4
Address: 3150 Almaden Expressway, San Jose, CA 95118
Phone: 408 708 9808
Last updated: 2024-12-31
ABVC BioPharma, Inc.
ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1702, ABV-1601, ABV-1701 Vitargus
ABVC Bio Pharma, Inc., based in Fremont, California, is a clinical stage biopharmaceutical company developing drugs and medical devices to address unmet medical needs in the United States. The company is involved in developing therapies for conditions such as cancer, major depressive disorders, and attention deficit hyperactivity disorder.
Symbol: ABVC
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Uttam Yashwant Patil Ph.D.
Sector: Healthcare
Employees: 16
Address: 44370 Old Warm Springs Boulevard, Fremont, CA 94538
Phone: 510 668 0881
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Novavax, Inc.
NVX-Co V2373
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.
Contact | Careers | Careers | Careers | Careers | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | About | About
Symbol: NVAX
Recent Price: $7.93
Industry: Biotechnology
CEO: Mr. John Charles Jacobs M.B.A.
Sector: Healthcare
Employees: 1543
Address: 21 Firstfield Road, Gaithersburg, MD 20878
Phone: 240 268 2000
Last updated: 2024-12-31
Revelation Biosciences, Inc.
REVTx-99b
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.
Symbol: REVB
Recent Price: $0.39
Industry: Biotechnology
CEO: Mr. James M. Rolke
Sector: Healthcare
Employees: 9
Address: 4660 La Jolla Village Drive, San Diego, CA 92122
Phone: 650-800-3717
Last updated: 2024-12-31
AlloVir, Inc.
posoleucel
Allovir, Inc. is a clinical-stage cell therapy company focused on the development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat viral-associated diseases. It was founded in 2013 and is based in Waltham, Massachusetts.
Symbol: ALVR
Recent Price: $0.45
Industry: Biotechnology
CEO: Dr. Diana M. Brainard M.D.
Sector: Healthcare
Employees: 8
Address: 1100 Winter Street, Waltham, MA 02451
Phone: 617 433 2605
Last updated: 2024-12-31
Assembly Biosciences, Inc.
Vebicorvir
Assembly Biosciences, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Their lead product candidate, Vebicorvir, has completed Phase 2 clinical trials. The company is engaged in additional development and collaboration agreements to advance treatments for HBV.
Symbol: ASMB
Recent Price: $16.03
Industry: Biotechnology
CEO: Mr. Jason A. Okazaki
Sector: Healthcare
Employees: 65
Address: 331 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 833 509 4583
Last updated: 2024-12-31
Atara Biotherapeutics, Inc.
T-cell immunotherapy treatments
Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.
About | About | About | Contact | About | Careers | Careers | About | Careers | Careers | About | About
Symbol: ATRA
Recent Price: $13.28
Industry: Biotechnology
CEO: Dr. Anhco Nguyen Ph.D.
Sector: Healthcare
Employees: 165
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 650 278 8930
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
HilleVax, Inc.
HIL-214
Hille Vax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines, including HIL-214, for the prevention of norovirus infection.
Symbol: HLVX
Recent Price: $1.98
Industry: Biotechnology
CEO: Dr. Robert M. Hershberg M.D., Ph.D.
Sector: Healthcare
Employees: 90
Address: 75 State Street, Boston, MA 02109
Phone: 617 213 5054
Last updated: 2024-12-31
Immunome, Inc.
IMM-ONC-01, IMM-BCP-01
Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.
Symbol: IMNM
Recent Price: $10.28
Industry: Biotechnology
CEO: Dr. Clay B. Siegall Ph.D.
Sector: Healthcare
Employees: 78
Address: 665 Stockton Drive, Exton, PA 19341
Phone: 610 321 3700
Last updated: 2024-12-31
Vaxcyte, Inc.
VAX-24
Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.
Symbol: PCVX
Recent Price: $81.99
Industry: Biotechnology
CEO: Mr. Grant E. Pickering M.B.A.
Sector: Healthcare
Employees: 254
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 837 0111
Last updated: 2024-12-31
SAB Biotherapeutics, Inc.
SAB-185, SAB-176
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.
Symbol: SABS
Recent Price: $4.15
Industry: Biotechnology
CEO: Mr. Samuel J. Reich
Sector: Healthcare
Employees: 57
Address: 2100 East 54th Street North, Sioux Falls, SD 57104
Phone: 605 679 6980
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason OβByrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Vaxxinity, Inc.
UB-311, UB-312, UB-313, UB-612
Vaxxinity, Inc. is a biotechnology company focused on developing product candidates for neurology and coronavirus-related treatments, including Alzheimer's, Parkinson's disease, migraines, and SARS-CoV-2.
Symbol: VAXX
Recent Price: $0.00
Industry: Biotechnology
CEO: Ms. Mei Mei Hu J.D.
Sector: Healthcare
Employees: 57
Address: 1717 Main Street, Dallas, TX 75201
Phone: 254 244 5739
Last updated: 2024-11-08
Vaxart, Inc.
Oral Recombinant Protein Vaccines
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant protein vaccines using a proprietary oral vaccine platform. Their product pipeline includes vaccines for norovirus, seasonal influenza, respiratory syncytial virus, and coronavirus, along with therapeutic vaccines for cervical cancer and dysplasia.
Symbol: VXRT
Recent Price: $0.69
Industry: Biotechnology
CEO: Mr. Steven Lo
Sector: Healthcare
Employees: 109
Address: 170 Harbor Way, South San Francisco, CA 94080
Phone: 650 550 3500
Last updated: 2024-12-31
XBiotech Inc.
True Human monoclonal antibodies
XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.
Symbol: XBIT
Recent Price: $4.09
Industry: Biotechnology
CEO: Mr. John Simard
Sector: Healthcare
Employees: 94
Address: 5217 Winnebago Lane, Austin, TX 78744
Phone: 512 386 2900
Last updated: 2024-12-31
Theriva Biologics, Inc.
SYN-004, SYN-020, VCN-01
Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.
Symbol: TOVX
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Steven A. Shallcross CPA
Sector: Healthcare
Employees: 22
Address: 9605 Medical Center Drive, Rockville, MD 20850
Phone: 301 417 4364
Last updated: 2024-12-31
Adaptive Biotechnologies Corporation
immunoSEQ
Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.
Leadership | Contact | About | About | About | About | Careers | Careers | About | About | About | About | About
Symbol: ADPT
Recent Price: $6.11
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A.
Sector: Healthcare
Employees: 709
Address: 1165 Eastlake Avenue East, Seattle, WA 98109
Phone: 206 659 0067
Last updated: 2024-12-31
Virios Therapeutics, Inc.
IMC-1
Virios Therapeutics, Inc. is a biotechnology company focused on developing antiviral therapies for diseases associated with a viral triggered abnormal immune response, including fibromyalgia and long COVID.
Symbol: VIRI
Recent Price: $0.15
Industry: Biotechnology
CEO: Mr. Gregory Duncan
Sector: Healthcare
Employees: 4
Address: 44 Milton Avenue, Alpharetta, GA 30009
Phone: 866 620 8655
Last updated: 2024-12-31